Niclosamide: Difference between revisions
Gerald Chi (talk | contribs) |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 26: | Line 26: | ||
'''| [[Niclosamide indications|Indications]]''' | '''| [[Niclosamide indications|Indications]]''' | ||
'''| [[Niclosamide contraindications|Contraindications]]''' | '''| [[Niclosamide contraindications|Contraindications]]''' | ||
'''| [[Niclosamide side effects|Side Effects]]''' | '''| [[Niclosamide side effects|Side Effects]]''' | ||
'''| [[Niclosamide overdosage|Overdosage]]''' | '''| [[Niclosamide overdosage|Overdosage]]''' | ||
Latest revision as of 21:13, 6 January 2014
| Niclosamide |
|---|
| YOMESAN® Package Insert |
| Clinical Pharmacology |
| Indications |
| Contraindications |
| Side Effects |
| Overdosage |
| Dosage |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Niclosamide is a teniacide ("tenia-" referring to tapeworm) in the anthelmintic family especially effective against cestodes that infect humans.
It is stressed that while anthelmintics are a drug familiy used to treat worm infections, Niclosamide is used specifically to treat tapeworms and is not effective against worms such as pinworms or roundworms.
It is a chewable tablet taken orally, dosage depending on type of worm and patient's age and/or weight.
Niclosamide molecules are lethal to tapeworms upon contact.
Category
Anthelmintic
US Brand Names
NICLOCIDE®, YOMESAN® (DISCONTINUED)
FDA Package Insert
Clinical Pharmacology | Indications | Contraindications | Side Effects | Overdosage | Dosage
Mechanism of Action
Niclosamide uncouples oxidative phosphorylation in the tapeworm.[1]
References
- ↑ Weinbach EC, Garbus J (1969). "Mechanism of action of reagents that uncouple oxidative phosphorylation". Nature. 221 (5185): 1016–8.